Aims: Increases in the systemic vasodilator adrenomedullin and the renal vasoconstrictors thromboxane A in cirrhotic patients are pathogenic factors for the development of functional acute kidney injury (AKI), including pre-renal azotemia (PRA) and hepatorenal syndrome (HRS), which is associated with high mortality. This study aims to find biomarkers that can diagnose HRS at an early stage, to enable treatment as soon as possible.
Methods: Acute decompensated cirrhotic patients who had been admitted to hospital were enrolled in this prospective cohort study. Blood and urinary samples were collected immediately after admission. In addition to initially categorizing AKI cases into PRA, acute tubular necrosis (ATN), and HRS groups, their final diagnosis was adjudicated by a nephrologist and a hepatologist who checked the corrected and misclassification rates for significant biomarkers.
Results: The cut-off values for serum adrenomedullin and urinary thromboxane B (TXB ), when used as predictors for functional AKI (adrenomedullin >283 pg/mL, urinary TXB >978 [pg/mg urinary creatinine]), for HRS (adrenomedullin >428, urinary TXB >1604), and for good terlipressin plus albumin treatment responders (adrenomedullin >490, urinary TXB >1863), were observed. Patients with HRS who could be treated, due to high mortality, had significantly higher serum adrenomedullin and urinary TXB levels compared to HRS patients receiving standard treatment. In addition to predicting 60-day mortality, a combination of these two markers further increased diagnostic accuracy for HRS among functional AKI.
Conclusions: Prompt diagnosis of HRS by differentiating it from PRA and ATN can be achieved by using serum adrenomedullin and urinary TXB in acute decompensated cirrhotic patients. In combination with severe clinical courses, these two markers are useful to select HRS patients who cannot be treated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/hepr.12917 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of Systemic Thromboxane Generation With Risk of Developing Heart Failure.
J Am Coll Cardiol
January 2025
Division of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Background: Systemic thromboxane A generation, which is readily assessed by quantifying thromboxane B metabolites (TXB-M) in the urine, is associated with impaired cardiac performance and mortality in aspirin (ASA) users with heart failure (HF).
Objectives: This study sought to determine the association of urinary TXB-M with the risk of developing HF in individuals without prior history of HF and with normal left ventricular function irrespective of ASA use.
Methods: Urine TXB-M were measured by immunoassay and adjusted to urine concentration and renal function (TXB-M) in 2,611 Framingham Heart Study participants (54.
Impact of Short-Term Diesel Exhaust Exposure on Prothrombotic Markers in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Crossover Study.
Ann Am Thorac Soc
December 2024
Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department of Medicine, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Growing evidence suggests that air pollution exposure is a major risk factor in chronic obstructive pulmonary disease (COPD) that is associated with an increased prothrombotic state and adverse cardiovascular outcomes. However, much of this work is based on observational data or human exposure studies involving younger participants. The biological causality and mechanism of air pollution-induced prothrombotic response in patients with COPD remain to be explored.
View Article and Find Full Text PDFOptimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action.
Front Pharmacol
February 2024
University Hospital LB, Aragon Health Research Institute (IISAragon), CIBERehd, University of Zaragoza, Zaragoza, Spain.
Low-dose aspirin's mechanism of action for preventing colorectal cancer (CRC) is still debated, and the optimal dose remains uncertain. We aimed to optimize the aspirin dose for cancer prevention in CRC patients through deep phenotyping using innovative biomarkers for aspirin's action. We conducted a Phase II, open-label clinical trial in 34 CRC patients of both sexes randomized to receive enteric-coated aspirin 100 mg/d, 100 mg/BID, or 300 mg/d for 3 ± 1 weeks.
View Article and Find Full Text PDFEffect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B and 8-iso-prostaglandin F levels in human urine samples by validated enzyme immunoassays.
Sci Rep
March 2024
Department of Bioethics and Safety, Section of Pharmacology, Catholic University School of Medicine, Rome, Italy.
Article Synopsis
- Biological samples, particularly urine, need to be stable over long-term storage and repeated freeze-thaw cycles to ensure accurate analysis of metabolites.
- This study evaluated the stability of specific metabolites related to arachidonic acid over a period of 10 years and during 10 freeze-thaw cycles using existing urine samples.
- Results showed that most metabolites remained stable over time and with cycles, but urinary 8-iso-PGF increased significantly after multiple freeze-thaw cycles when no antioxidants were used, highlighting the importance of storage conditions.
Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial.
J Vet Pharmacol Ther
May 2024
Department of Comparative Biomedical Sciences, Royal Veterinary College, University of London, London, UK.
We evaluated the effect of administration timing of meloxicam and robenacoxib on renal function, platelet cyclo-oxygenase and perioperative analgesia in 60 cats undergoing ovariohysterectomy, in a prospective randomized blinded controlled study. Twelve cats were randomly allocated to one subcutaneous treatment group: meloxicam (0.2 mg/kg) or robenacoxib (2 mg/kg) at admission (MA, RA), at induction (MI, RI) and robenacoxib at the end of surgery (RE).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!